Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1997-2-21
pubmed:abstractText
Optimum conditions were determined for the solubilisation of native NMDA receptors of adult mammalian brain with the retention of [3H]MK-801 radioligand binding activity. The most efficient conditions were 1% Triton X-100/1 M NaCl. The efficiency of solubilisation was as follows: cloned NMDA receptors expressed in mammalian cells > forebrain receptors > cerebellar receptors. Triton X-100/1 M NaCl-solubilised forebrain NMDA receptors had a molecular size of 710,000 daltons, but significant NR1 immunoreactivity (41%) migrated as a monomer of 125,000 daltons. Immunoaffinity purification of NMDA receptors from forebrain by anti-NR1 911-920 antibody affinity chromatography from 1% Triton X-100/1 M NaCl solubilised extracts yielded purification of the NR1 Mr 120,000 immunoreactive species, but no detectable NR2A or NR2B immunoreactivity. Immunoprecipitation of NMDA receptors from Triton X-100/1 M NaCl extracts with anti-NR1 911-920 antibodies also resulted in precipitation of NR1 subunits, but with no detectable NR2A or NR2B subunits. In contrast, by immunoprecipitation with anti-NR1 17-35 antibodies, which recognise all forms of NR1, NR1, NR2A, and NR2B immunoreactivities were detected in the immune pellets. Similarly, a co-association of NR1, NR2A, and NR2B subunits was demonstrated following extraction of forebrain membranes with 1% sodium deoxycholate (pH 9) and purification by anti-NR1 911-920 antibody affinity chromatography. These results are consistent with the identification of a pool of unassembled C2 exon-containing NR1 subunits, i.e., NR1-1a, NR1-1b, NR1-2a, and NR1-2b, selectively solubilised by 1% Triton X-100/1 M NaCl.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0022-3042
pubmed:author
pubmed:issnType
Print
pubmed:volume
68
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
507-16
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9003035-Age Factors, pubmed-meshheading:9003035-Alternative Splicing, pubmed-meshheading:9003035-Animals, pubmed-meshheading:9003035-Antibody Specificity, pubmed-meshheading:9003035-Cerebellum, pubmed-meshheading:9003035-Chromatography, Affinity, pubmed-meshheading:9003035-Chromatography, Gel, pubmed-meshheading:9003035-Detergents, pubmed-meshheading:9003035-Exons, pubmed-meshheading:9003035-Gene Expression, pubmed-meshheading:9003035-Humans, pubmed-meshheading:9003035-Kidney, pubmed-meshheading:9003035-Mice, pubmed-meshheading:9003035-Molecular Weight, pubmed-meshheading:9003035-Precipitin Tests, pubmed-meshheading:9003035-Prosencephalon, pubmed-meshheading:9003035-Receptors, N-Methyl-D-Aspartate, pubmed-meshheading:9003035-Solubility, pubmed-meshheading:9003035-Transfection
pubmed:year
1997
pubmed:articleTitle
Biochemical evidence for the existence of a pool of unassembled C2 exon-containing NR1 subunits of the mammalian forebrain NMDA receptor.
pubmed:affiliation
Department of Pharmaceutical and Biological Chemistry, School of Pharmacy, London, England.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't